Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority

Lignende værker

• Direct oral anticoagulants for unusual‐site venous thromboembolism
  af: Riva, Nicoletta, et al.
  Udgivet: (2021)
• Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants
  af: Patel, Raj
  Udgivet: (2016)
• Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study
  af: Riva, Nicoletta, et al.
  Udgivet: (2015)
• D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants
  af: Legnani, Cristina, et al.
  Udgivet: (2019)
• Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism
  af: Keita, Ingre, et al.
  Udgivet: (2017)